The delivery may be expected in the first half of the month, the RDIF head assured.
Earlier on Friday, the Philippines became the 52nd country to authorize Russia's Sputnik V vaccine. The vaccine was registered under the emergency use authorisation procedure.
In February, the peer-reviewed medical journal, The Lancet, published an interim analysis from the Phase III clinical trials of the Russian vaccine, showing its 91.6-percent efficacy against symptomatic COVID-19.
Developed by the Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V was the world's first officially-registered vaccine against COVID-19.